A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin
Amorphous solid dispersions (ASDs) based on proteins as co-formers have previously shown promising potential to improve the solubility and bioavailability of poorly water-soluble drugs. In particular, whey proteins have shown to be promising co-formers and amorphous stabilizers in ASD formulations,...
Saved in:
Main Authors: | Xuezhi Zhuo (Author), Maud Margrethe Brekstad Kjellin (Author), Zarah Schaal (Author), Tengyu Zhang (Author), Korbinian Löbmann (Author), Donglei Leng (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Influence of Pressure on the Intrinsic Dissolution Rate of Amorphous Indomethacin
by: Korbinian Löbmann, et al.
Published: (2014) -
Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations
by: Jaya Mishra, et al.
Published: (2018) -
Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies
by: Jingwen Liu, et al.
Published: (2021) -
Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
by: Katrine Tarp Jensen, et al.
Published: (2014) -
Enabling formulations of aprepitant: in vitro and in vivo comparison of nanocrystalline, amorphous and deep eutectic solvent based formulations
by: Henrik Palmelund, et al.
Published: (2021)